SCHEMBL3624037

SCHEMBL3624037

CCOC(=O)[C@H](CCC[C@H](C)N[S@@+]([O-])C(C)(C)C)NC(=O)OC(C)(C)C

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 1/20 0.46
CYP2C9 P11712 1/20 0.46
CYP2C19 P33261 1/20 0.46
HTT P42858 1/20 0.46
CTSK P43235 10/20 0.44
SMN1; SMN2 Q16637 1/20 0.41
CTSS P25774 3/20 0.40
ALDH1A1 P00352 3/20 0.39
MAPT P10636 3/20 0.39
KDM4E B2RXH2 1/20 0.37
GAA P10253 1/20 0.37
PKM P14618 1/20 0.37
HPGD P15428 1/20 0.37
ALOX12 P18054 1/20 0.37
CAPN1 P07384 1/20 0.35
POLB P06746 1/20 0.35
KMT2A Q03164 1/20 0.35
CA1 P00915 1/20 0.35
CA2 P00918 1/20 0.35
CA7 P43166 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8068921 1.00 CYP1A2 (0.46) CYP1A2CYP2C9CYP2C19HTTCTSK
SCHEMBL8061219 0.80 CYP1A2 (0.54) CYP1A2CYP2C9CYP2C19HTTCTSK
SCHEMBL3619598 0.80 CYP1A2 (0.54) CYP1A2CYP2C9CYP2C19HTTCTSK
SCHEMBL26447937 0.76 CYP1A2 (0.58) CYP1A2CYP2C9CYP2C19HTTCTSK
SCHEMBL29508434 0.75 CYP1A2 (0.61) CYP1A2CYP2C9CYP2C19HTTCTSK
SCHEMBL14483921 0.75 CYP1A2 (0.61) CYP1A2CYP2C9CYP2C19HTTCTSK
SCHEMBL13560958 0.75 CYP1A2 (0.61) CYP1A2CYP2C9CYP2C19HTTCTSK
SCHEMBL30867222 0.75 CYP1A2 (0.54) CYP1A2CYP2C9CYP2C19HTTCTSK
SCHEMBL29411192 0.75 CYP1A2 (0.54) CYP1A2CYP2C9CYP2C19HTTCTSK
SCHEMBL4278142 0.75 CYP1A2 (0.54) CYP1A2CYP2C9CYP2C19HTTCTSK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100093811-A1 HIV PROTEASE INHIBITORS MERCK SHARP & DOHME CORP. 2010-04-15 US disclosed
US-20100093811-A1 HIV PROTEASE INHIBITORS MERCK SHARP & DOHME CORP. 2010-04-15 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100093811-A1 HIV PROTEASE INHIBITORS PRSS1, FURIN, SERPINB1 CYP1A2 728/4885CYP2C9 711/4885CYP2C19 690/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.